Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
PRODUKTE
Produktbeschreibung
Produktdetails
Hochwertige Selexipag Intermediate CAS -Nr . 243472-70-0 :
CAS-Nr.: 243472-70-0
Name: selexipag intermediate
Aussehen: weiße bis weiße Pulver
Reinheit: 99%+
Selexipag (Markenname UPtravi) ist ein Medikament, das von Actelion zur Behandlung der pulmonalen arteriellen Hypertonie (PAH) entwickelt wurde. Selexipag und sein aktiver Metabolit, Akt-333679 (oder MRE-269, die freie Carboxylsäure), sind Agonisten des Prostacyclin-Rezeptors, was zu einer Vasodilatation in der Lungenzirkulation führt.
Wir sind Hersteller von API, Rohstoff Pharma, pharmazeutischen Zwischenprodukten, aktiven pharmazeutischen Inhaltsstoffen, agrochemischen Zwischenprodukten und Feinschemikalien.
YOU MIGHT ALSO LIKE
In Kontakt kommen
If you have any questions our products or services,feel free to reach out to us.Provide unique experiences for everyone involved with a brand. we’ve got preferential price and best-quality products for you.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.